Developer of cancer therapies designed to provide personalized anticancer treatment. The company's solution, based on a novel antigen discovery platform, combines with actual immune cells beyond inacc...

Healthcare
Seoul, South Korea
Founded 2020
16 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$13.7M
Last Round
N/A

Get the full picture

Create a free account to unlock NeogenTC's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required